Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer

Irene Stasi, Federico Cappuzzo
  • Translational Respiratory Medicine, January 2014, Springer Science + Business Media
  • DOI: 10.1186/2213-0802-2-2

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1186/2213-0802-2-2

The following have contributed to this page: Dr Federico Cappuzzo

In partnership with: